Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

被引：81

作者：

Ciurea, Stefan O. ^{[1
]}

Chilkulwar, Abhishek ^{[1
]}

Saliba, Rima M. ^{[1
]}

Chen, Julianne ^{[1
]}

Rondon, Gabriela ^{[1
]}

Patel, Keyur P. ^{[2
]}

Khogeer, Haitham ^{[2
]}

Shah, Abdul R. ^{[1
]}

Randolph, Brion V. ^{[1
]}

Perez, Jorge M. Ramos ^{[1
]}

Popat, Uday ^{[1
]}

Hosing, Chitra M. ^{[1
]}

Bashir, Qaiser ^{[1
]}

Mehta, Rohtesh ^{[1
]}

Al-Atrash, Gheath ^{[1
]}

Im, Jin ^{[1
]}

Khouri, Issa F. ^{[1
]}

Kebriaei, Partow ^{[1
]}

Champlin, Richard E. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, 1515 Holcombe Blvd,Unit 423, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

来源：

BLOOD | 2018年 / 131卷 / 26期

关键词：

ACUTE MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; MYELODYSPLASTIC SYNDROME; MARROW TRANSPLANTATION; WORKING PARTY; IMPACT; ABNL(17P); ADULTS; BLOOD;

D O I：

10.1182/blood-2018-02-832360

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2989 / 2992

页数：6

共 16 条

[1] Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status [J].

Aldoss, Ibrahim ;

Pham, Anh ;

Li, Sierra Min ;

Gendzekhadze, Ketevan ;

Afkhami, Michelle ;

Telatar, Milhan ;

Hong, Hao ;

Padeganeh, Abbas ;

Bedell, Victoria ;

Cao, Thai ;

Khaled, Samer K. ;

Al Malki, Monzr M. ;

Salhotra, Amandeep ;

Ali, Haris ;

Aribi, Ahmed ;

Palmer, Joycelynne ;

Aoun, Patricia ;

Spielberger, Ricardo ;

Stein, Anthony S. ;

Snyder, David ;

O'Donnell, Margaret R. ;

Murata-Collins, Joyce ;

Senitzer, David ;

Weisenburger, Dennis ;

Forman, Stephen J. ;

Pullarkat, Vinod ;

Marcucci, Guido ;

Pillai, Raju ;

Nakamura, Ryotaro .

HAEMATOLOGICA, 2017, 102 (12) :2030-2038

[2] Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation [J].

Baron, F. ;

Labopin, M. ;

Niederwieser, D. ;

Vigouroux, S. ;

Cornelissen, J. J. ;

Malm, C. ;

Vindelov, L. L. ;

Blaise, D. ;

Janssen, J. J. W. M. ;

Petersen, E. ;

Socie, G. ;

Nagler, A. ;

Rocha, V. ;

Mohty, M. .

LEUKEMIA, 2012, 26 (12) :2462-2468

[3] TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis [J].

Bowen, D. ;

Groves, M. J. ;

Burnett, A. K. ;

Patel, Y. ;

Allen, C. ;

Green, C. ;

Gale, R. E. ;

Hills, R. ;

Linch, D. C. .

LEUKEMIA, 2009, 23 (01) :203-206

[4] Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation [J].

Ciurea, Stefan O. ;

Schafer, Jolie R. ;

Bassett, Roland ;

Denman, Cecele J. ;

Cao, Kai ;

Willis, Dana ;

Rondon, Gabriela ;

Chen, Julianne ;

Soebbing, Doris ;

Kaur, Indreshpal ;

Gulbis, Alison ;

Ahmed, Sairah ;

Rezvani, Katayoun ;

Shpall, Elizabeth J. ;

Lee, Dean A. ;

Champlin, Richard E. .

BLOOD, 2017, 130 (16) :1857-1868

[5]

Della Porta MG, J CLIN ONCOL, DOI [10.1200/JCO.2016.67.3616, DOI 10.1200/JCO.2016.67.3616]

[6] MUTATIONS OF THE P53-GENE IN ACUTE MYELOID-LEUKEMIA [J].

FENAUX, P ;

PREUDHOMME, C ;

QUIQUANDON, I ;

JONVEAUX, P ;

LAI, JL ;

VANRUMBEKE, M ;

LOUCHEUXLEFEBVRE, MH ;

BAUTERS, F ;

BERGER, R ;

KERCKAERT, JP .

BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (02) :178-183

[7] A novel hierarchical prognostic model of AML solely based on molecular mutations [J].

Grossmann, Vera ;

Schnittger, Susanne ;

Kohlmann, Alexander ;

Eder, Christiane ;

Roller, Andreas ;

Dicker, Frank ;

Schmid, Christoph ;

Wendtner, Clemens-Martin ;

Staib, Peter ;

Serve, Hubert ;

Kreuzer, Karl-Anton ;

Kern, Wolfgang ;

Haferlach, Torsten ;

Haferlach, Claudia .

BLOOD, 2012, 120 (15) :2963-2972

[8] TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes [J].

Kadia, Tapan M. ;

Jain, Preetesh ;

Ravandi, Farhad ;

Garcia-Manero, Guillermo ;

Andreef, Michael ;

Takahashi, Koichi ;

Borthakur, Gautam ;

Jabbour, Elias ;

Konopleva, Marina ;

Daver, Naval G. ;

Dinardo, Courtney ;

Pierce, Sherry ;

Kanagal-Shamanna, Rashmi ;

Patel, Keyur ;

Estrov, Zeev ;

Cortes, Jorge ;

Kantarjian, Hagop M. .

CANCER, 2016, 122 (22) :3484-3491

[9] Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation [J].

Kim, M. ;

Yahng, S-A ;

Kwon, A. ;

Park, J. ;

Jeon, Y-W ;

Yoon, J-H ;

Shin, S-H ;

Lee, S-E ;

Cho, B-S ;

Eom, K-S ;

Lee, S. ;

Min, C-K ;

Kim, H-J ;

Cho, S-G ;

Kim, D-W ;

Lee, J-W ;

Min, W-S ;

Lee, S-H ;

Kim, Y-J .

BONE MARROW TRANSPLANTATION, 2015, 50 (08) :1132-1134

[10] Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation [J].

Lindsley, R. C. ;

Saber, W. ;

Mar, B. G. ;

Redd, R. ;

Wang, T. ;

Haagenson, M. D. ;

Grauman, P. V. ;

Hu, Z. -H. ;

Spellman, S. R. ;

Lee, S. J. ;

Verneris, M. R. ;

Hsu, K. ;

Fleischhauer, K. ;

Cutler, C. ;

Antin, J. H. ;

Neuberg, D. ;

Ebert, B. L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (06) :536-547

← 1 2 →